Commentary: Triptan Use During Pregnancy: A Safe Choice?
Full disclosure: Dr. Kurth has received within the last 2 years investigator-initiated research funding from the US National Institutes of Health, the French National Research Agency, the Migraine Research Foundation, and Merck. Further, he is a consultant to i3 Drug Safety and World Health Information Science Consultants, LLC; he has received honoraria from Genzyme, Merck, and Pfizer for educational lectures. Dr. Hernandez-Diaz has received within the last 2 years investigator-initiated research funding from the US National Institutes of Health. She has received unrestricted training grants from Pfizer, Novartis, and Wyeth, has been a consultant for AstraZeneca and Novartis. She is a consultant to World Health Information Science Consultants, LLC.
T. Kurth, INSERM Unit 708 – Neuroepidemiology, Hôpital de la Pitié-Salpêtrière, 47 boulevard de l'Hôpital, 75651 Paris Cedex 13, France.
No abstract is available for this article.